- Investing Ideas
- U.K. Pharmaceuticals & Biotech High Insider Buying
U.K. Pharmaceuticals & Biotech High Insider Buying
Results
6
Stocks with high levels of insider buying the past 3 months and good analyst coverage.
6 companies
Haleon
Market Cap: UK£30.7b
Engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific.
HLN
UK£3.48
7D
4.2%
1Y
-7.4%
Hikma Pharmaceuticals
Market Cap: UK£3.2b
Develops, manufactures, markets, and sells a range of generic, specialty, and branded pharmaceutical products.
HIK
UK£15.20
7D
0.3%
1Y
-23.7%
Oxford Nanopore Technologies
Market Cap: UK£1.2b
Engages in the research, development, manufacture, and commercialization of a novel generation of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) sequencing technology that allows analysis of DNA or RNA.
ONT
UK£1.24
7D
8.2%
1Y
-10.7%
Animalcare Group
Market Cap: UK£230.6m
Develops, sells, and distributes licensed veterinary pharmaceuticals for the companion animal, production animal, and equine veterinary markets in Europe, the Asia-Pacific, and internationally.
ANCR
UK£3.34
7D
0.8%
1Y
13.6%
Bioventix
Market Cap: UK£86.2m
Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide.
BVXP
UK£16.50
7D
-8.3%
1Y
-45.4%
OptiBiotix Health
Market Cap: UK£6.6m
A life sciences company, engages in the discovery and development of microbiome modulation products in the United Kingdom, the United States, India, China, and internationally.
OPTI
UK£0.064
7D
4.9%
1Y
-43.7%